ES293991A1 - Un procedimiento para fabricar derivados de piridina - Google Patents

Un procedimiento para fabricar derivados de piridina

Info

Publication number
ES293991A1
ES293991A1 ES293991A ES293991A ES293991A1 ES 293991 A1 ES293991 A1 ES 293991A1 ES 293991 A ES293991 A ES 293991A ES 293991 A ES293991 A ES 293991A ES 293991 A1 ES293991 A1 ES 293991A1
Authority
ES
Spain
Prior art keywords
compounds
formula
hydrogen
subsequently
intermediates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES293991A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES293991A1 publication Critical patent/ES293991A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • C07D213/67—2-Methyl-3-hydroxy-4,5-bis(hydroxy-methyl)pyridine, i.e. pyridoxine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36—One oxygen atom
    • C07D263/42—One oxygen atom attached in position 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Air Transport Of Granular Materials (AREA)
ES293991A 1962-11-29 1963-11-28 Un procedimiento para fabricar derivados de piridina Expired ES293991A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US241019A US3250778A (en) 1962-11-29 1962-11-29 Intermediates for and synthesis of vitamin b and related compounds

Publications (1)

Publication Number Publication Date
ES293991A1 true ES293991A1 (es) 1964-05-16

Family

ID=22908910

Family Applications (1)

Application Number Title Priority Date Filing Date
ES293991A Expired ES293991A1 (es) 1962-11-29 1963-11-28 Un procedimiento para fabricar derivados de piridina

Country Status (9)

Country Link
US (1) US3250778A (es)
BR (1) BR6354482D0 (es)
CH (1) CH427795A (es)
DE (1) DE1445882A1 (es)
DK (2) DK109037C (es)
ES (1) ES293991A1 (es)
GB (2) GB1013894A (es)
NO (1) NO122836B (es)
SE (1) SE308522B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH451137A (de) * 1964-05-27 1968-05-15 Hoffmann La Roche Verfahren zur Herstellung von Pyridinderivaten
US3429897A (en) * 1965-10-21 1969-02-25 Merck & Co Inc 3,6-dihydro-1,2-dioxin and its method of production
US3365461A (en) * 1965-10-21 1968-01-23 Merck & Co Inc Process for preparing pyridoxine
US3364226A (en) * 1965-10-21 1968-01-16 Merck & Co Inc Method for preparing pyridoxine and intermediates therefor
US3408359A (en) * 1965-10-21 1968-10-29 Merck & Co Inc 7-methyl-8-hydroxy-1, 4-dihydro-o-dioxin(4, 5-c)pyridine
US3410856A (en) * 1965-10-21 1968-11-12 Merck & Co Inc Intermediates and process for preparing vitamin b6
US3525749A (en) * 1969-03-19 1970-08-25 Merck & Co Inc Certain 1,3-dioxepino-(5,6-c)-pyridines
US4011231A (en) * 1975-10-03 1977-03-08 Pfizer Inc. 2-Phenyl-6-(1-hydroxy-2-t-butylaminoethyl)-4H-pyrido[3,2-d]-1,3-dioxin maleate and its use as an intermediate
DE10261271A1 (de) * 2002-12-27 2004-07-08 Basf Ag Verfahren zur Herstellung von Pyridoxin oder seines Säureadditionssalzes
EP1685133A1 (en) * 2003-11-19 2006-08-02 DSM IP Assets B.V. Manufacture of vitamin b6
CN109956899B (zh) * 2017-12-14 2021-01-22 新发药业有限公司 一种维生素b6的制备方法
CN114149442A (zh) * 2021-12-08 2022-03-08 华中药业股份有限公司 一种杂质ts-3b的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2260261A (en) * 1941-10-21 Cyclic ketals and process for
US2312743A (en) * 1939-12-01 1943-03-02 Standard Oil Dev Co Alkoxy meta-dioxanes
US2520038A (en) * 1948-04-14 1950-08-22 American Cyanamid Co Process for preparing pyridoxine hydrochloride
US2875207A (en) * 1953-11-30 1959-02-24 Sadolin & Holmblad As Process for the preparation of vitamin b6, intermediates employed therein, and processes of preparing the same
US2870097A (en) * 1955-07-01 1959-01-20 Du Pont Process for the preparation of polymeric acetals

Also Published As

Publication number Publication date
BR6354482D0 (pt) 1973-07-03
NO122836B (es) 1971-08-23
SE308522B (es) 1969-02-17
DK109037C (da) 1968-03-11
DK115330B (da) 1969-09-29
GB1013894A (en) 1965-12-22
CH427795A (de) 1967-01-15
US3250778A (en) 1966-05-10
DE1445882A1 (de) 1968-11-28
GB1013893A (en) 1965-12-22

Similar Documents

Publication Publication Date Title
GB1164825A (en) New N-Substituted Nitro-Anilines
ES481873A1 (es) Procedimiento para la preparacion de 2-(2-alcoxietil)-2'- hidroxi-6,7-benzomorfanos.
ES293991A1 (es) Un procedimiento para fabricar derivados de piridina
SE7905402L (sv) Fenyl-piperazinderivat
ES8706608A1 (es) Un procedimiento para preparar derivados de arilciclobutilalquilamina
ES405983A1 (es) Procedimiento para la preparacion de derivados de fenileti-lamina fluoralcohilados.
GB1087243A (en) Improvements in or relating to naphthalene derivatives and the manufacture thereof
SE7906011L (sv) Nya imidazokinoxaliner och salter derav, sett for framstellning och anvendning derav sasom lekemedel samt farmaceutiska kompositioner innehallande dessa foreningar
ES8200648A2 (es) Procedimiento de preparacion de compuestos opacificantes para radiografia y similares
GB1096301A (en) 1,4-benzodioxane derivatives
JPS5265267A (en) Synthesis of spiro compounds
ES456400A1 (es) Un procedimiento para la preparacion de derivados de tieno- tiacina.
ES451067A1 (es) Un procedimiento de preparacion de derivados de fenotiazina.
ES8200347A1 (es) Procedimiento de preparacion de derivados de la piridina.
GB1269776A (en) Epoxides and halohydrins and conversion thereof to alkanolamine derivatives
ES448439A1 (es) Procedimiento para la preparacion de nuevos de diacina.
ES485801A1 (es) Un procedimiento de preparacion de ciclo-1,3,2-oxazafosfo- ril-derivados
ATE13764T1 (de) N-phthalidyl-5-fluor-uracil-abkoemmlinge.
ES488388A1 (es) Procedimiento de preparacion de derivados hidroxilados del tiazol
GB2013497A (en) Herbicides
FR2372820A1 (fr) Procede de preparation de derives d'alcenyl-6 oxa-2 bicyclo (3-3-0) octanones-3, intermediaires pour la preparation de prostaglandines
ES441437A1 (es) Procedimiento para la preparacion de crotonanilidas susti- tuidas.
ES485392A1 (es) Un procedimiento para la preparacion de derivados de amino- alcoholes.
GB856352A (en) Heterocyclic compounds and methods for producing the same
ES8201963A1 (es) Un procedimiento para la preparacion de esteres de oxima